To implement chlorine 35 ( 35 Cl) magnetic resonance (MR) at a 7-T whole-body MR system and evaluate its feasibility for imaging humans.
Na. In vivo T2* was biexponential and extremely short. Monoexponential fits of T1 revealed 9.2 and 4.0 milliseconds ± 0.7 (standard deviation) for brain and muscle, respectively. In glioblastoma tissue, increased Cl 2 concentrations and increased Cl 2 IR signal intensities were detected. Voxel dimension and acquisition time, respectively, were 6 mm 3 ; total acquisition time, 35 minutes).
Conclusion:
MR at 7 T enables in vivo imaging of 35 Cl in human brain and muscle in clinically feasible acquisition times (10-35 minutes) and voxel volumes (0.2-1.3 cm 3 ). Pathophysiological changes of Cl 2 homeostasis due to cancer or muscular ion channel disease can be visualized.
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examined to determine the longitudinal relaxation time (T1) of brain tissue; three volunteers aged 20, 37, and 67 years old were examined to determine the transverse relaxation time as affected by magnetic field heterogeneity (T2*) of brain tissue; and one volunteer aged 67 years old was examined to test the 35 Cl MR imaging protocol. Four healthy volunteers aged 19, 43, 47 , and 73 years old underwent a muscle examination to determine the Cl 2 concentration and the T2*, and three healthy volunteers aged 25, 50, and 68 years old were examined to determine T1. In addition, two female patients who were 67 and 72 years old and had histopathologically confirmed glioblastoma multiforme and two female patients who were 28 and 44 years old and had genetically confirmed hypokalemic periodic paralysis (harboring the l-type calcium-channel mutation R1239H [15] ) underwent brain and calf muscle examinations, respectively.
by means of MR imaging very challenging. Nevertheless, 23 Na MR imaging has become a valuable and established tool in clinical research (3) (4) (5) . Furthermore, the feasibility of 39 K MR imaging of human muscle (6) and brain (6, 7) in vivo has recently been demonstrated with 7-T (6) and 9.4-T (7) whole-body MR systems. Although 35 Cl exhibits even lower MR imaging sensitivity than 23 Na (8) and only slightly higher MR imaging sensitivity than 39 K, imaging of 35 Cl could be an important advance. 35 Cl is the important anion that is involved in many fundamental physiological processes, such as the inhibition of muscular (9) and neuronal cells (10) . Also, it is involved in cell volume regulation (11) and cell migration in cancer (12, 13) . Skeletal muscle cells, for instance, exhibit a very high Cl 2 conductance, which makes up approximately 80% of the total membrane conductance at rest (14) . Therefore, it follows that the Goldman-Hodgkin-Katz equation can be approximated by the Nernst equation:
(1)
The inherent advantage of the Nernst equation is that only intra-([Cl] int ) and extracellular ([Cl] ext ) Cl 2 concentrations are required to calculate the resting membrane potential (U) of muscle cells. In various muscle diseases (eg, periodic paralyses [14] ), the resting membrane potential is reduced. Therefore, the purpose of this work was to implement 35 Cl MR imaging with a 7-T whole-body MR imaging system and to evaluate its feasibility for imaging of humans.
Materials and Methods
All examinations were performed with ethical review board approval of Heidelberg University (Heidelberg, Germany n Pathophysiological changes of the Cl 2 homeostasis due to glioblastoma or muscular ion channel disease can be visualized by using 35 Cl MR imaging. sequences a and b) . The k-space data were regridded with an oversampling ratio of two to a Cartesian grid by using a Kaiser-Bessel kernel (20) , followed by a conventional fast Fourier transform. Filtering and fast T2* decay lead to a broadening of the full width at half maximum of the point spread function (PSF). Thus, the effective spatial resolution is lower than the nominal spatial resolution. To quantify the additional loss in spatial resolution caused by the fast T2* decay of 35 Cl, the PSFs were simulated by using measured 35 Cl relaxation times and the applied pulse sequence parameters (Table 1) .
Phantom Studies SNR was determined according to the definition of the National Electrical Manufacturers Association (21) . Image noise was determined by using noiseonly images. SNRs were measured by using a spherical phantom containing 2.6 L of NaCl solution without agar gel (concentration, 154 mmol/L). For comparison of SNR between 35 Cl MR imaging and 23 Na MR imaging, the sequence parameters (Table 1 , sequences a and b, respectively) were chosen in a way that saturation effects could be neglected (TR much greater than T1) and T2* relaxation effects were minimized (TE much less than T2*).
The NaCl solutions (concentration, 154 mmol/L) containing different agar gel concentrations (0%, 1%, 2%, 3%, 4%, 5%) were examined to compare 23 Na and 35 Cl relaxation times. For the preparation of the phantoms, agar (Carl Roth, Karlsruhe, Germany) was dissolved in the NaCl solution and heated up to 90°C with stirring. For all measurements, NaCl with natural abundances of 23 Na (100%) and 35 Cl (75.8%) were used (ie, 154 mmol/L NaCl contains 117 mmol/L 35 Cl). To determine T1, 31 35 Cl and 23 23 Na 3D density-adapted-projection reconstruction inversion-recovery (IR) sequences with different inversion times (TIs) were applied (TI for (17) . 35 Cl MR imaging was conducted with a 7-T whole-body MR system (Magnetom 7T; Siemens Healthcare, Erlangen, Germany) by using a doubleresonant ( 35 Cl and 1 H) high-pass quadrature birdcage coil with 12 rungs, an inner coil diameter of 22 cm, and a length of 23 cm (QED, Mayfield Village, Ohio). The 7-T system and also the 35 Cl and 1 H coil are operated as investigational devices. However, except for the magnetic field strength, all limits of the International Electrotechnical Commission guideline-including specific absorption rate limits at the 35 Cl frequency-are applied in the same manner as for MR imaging at lower magnetic field strengths (18) . To compare relaxation times and signal-to-noise ratios (SNRs), 23 Na MR imaging was performed by using a double-resonant ( 23 Na and 1 H) quadrature birdcage coil with an inner coil diameter of 26 cm (Rapid Biomed, Rimpar, Germany).
Imaging Protocol All 23
Na and 35 Cl images were acquired with a three-dimensional (3D) density-adapted-projection reconstruction technique with isotropic spatial resolution (19) . This technique samples kspace on radial lines to achieve short echo times (TEs) of less than 1 millisecond. In contrast to conventional 3D radial acquisition techniques, where k-space is sampled with constant gradient amplitude (ie, constant velocity in k-space), the gradient amplitude is reduced in the outer part of kspace to achieve a more homogeneous distribution of the sampling points. This leads to higher SNR and fewer artifacts compared with conventional 3D radial acquisition techniques. Image reconstruction was performed offline (Matlab; MathWorks, Natick, Mass). The acquired k-space data were filtered to reduce Gibbs ringing artifacts by using a Hamming filter. No filter was Table 1 Parameters of the Note.-Acquisition time = total acquisition time, readout = readout duration, FOV = field of view, length = length of trapezoidal part of readout gradient, no. of data = number of acquired data points during one readout gradient, resolution = nominal spatial resolution, strength = maximum gradient strength, T1M = T1 measurement, T2*M = T2* measurement. The TE is defined from the center of the excitation pulse to the beginning of the signal acquisition. The total acquisition time was determined as the product of the repetition time (TR) and the number of radial projections. The flip angles are only given for the excitation pulses, since all inversion pulses had a flip angle of 180°. The shape of the readout was defined by the readout duration, the maximum gradient strength, and the length of the trapezoidal part of the readout gradient. The gradient shape determines the nominal spatial resolution. Filtering and fast T2* decay lead to a broadening of the full width at half maximum (full width at half maximum without T2* decay, approximately 2.0 pixels) of the PSF. Thus, the effective spatial resolution was lower than the nominal spatial resolution. To quantify this loss in spatial resolution, the PSF was simulated by using measured T2* relaxation times of 35 Cl. For 35 Cl MR imaging, higher gradient strengths were required to achieve the same resolution as for 23 Na MR imaging, because of lower gyromagnetic ratio of 35 Cl (cf, lower resonance frequency of 35 Cl). Additional details of the density-adapted-projection reconstruction pulse sequence can be found in Nagel et al (19) .
* In milliseconds, TE 23 Na MR imaging, were each performed without repositioning the patient. Therefore, no registration was performed. section thickness, 1.5 mm; total acquisition time , 2 minutes 3 seconds). Before postprocessing with the FMRIB Software (registration), the 3D data sets were interpolated to a matrix size of 300 3 300 3 300 voxels, by using the linear interpolation algorithm of the "interp3" function of the Matlab software (MathWorks, Natick, Mass). Anatomic 3-T 1 H images obtained in the patient with glioblastoma were registered to the 7-T 1 H MR imaging data by using a rigid body algorithm with 6 degrees of freedom (FLIRT [24] , part of FSL). The obtained registration matrix was then applied to the 23 Na and 35 Cl data.
In Vivo Studies (Calf Muscle)
Ten IR sequences were applied to determine T1 relaxation times of calf muscle from three healthy volunteers (TI, 3 Table 1 , sequence m]) were also performed for one patient with glioblastoma. Reference tubes were used for signal intensity normalization, as described in the figure legends. Measured T1 and T2* of NaCl solution and brain tissue were used to calculate a correction factor. The determined signal intensities of brain tissue were multiplied by this correction factor to calculate the Cl
To compare the nonproton data with conventional MR imaging for the patients with glioblastoma, T1-weighted images were acquired for the clinical routine workup by using a 3-T MR system (Magnetom Tim Trio; Siemens Healthcare) before and after administration of a standard dose of 0.1 mmol per kilogram of body weight of gadobutrol (Gadavist; Bayer Health Care, Wayne, NJ) as contrast medium and a T1-weighted contrast material-enhanced 3D magnetizationprepared rapid acquisition with gradient-echo sequence. Parameters were as follows: TR msec/TE msec/TI msec, 1710/4/1100; in-plane resolution, 0.5 3 0.5 mm 2 ; number of sections, 128; section thickness, 1.3 mm; and total acquisition time, 7 minutes 37 seconds. T2-weighted fluid-attenuated IR imaging was performed with the following parameters: 8500/133/2400; in-plane resolution, 0.9 3 0.9 mm 2 ; number of sections, 25; section thickness, 5 mm; and total acquisition time, 3 minutes 9 seconds.
Image postprocessing was performed with software (Matlab, MathWorks; FSL, FMRIB Software Library, Oxford, England) (22, 23 36 mmol/L (Fig 2a) . Analogous to IR techniques in 23 Na MR imaging, techniques that suppress signal from extracellular compartments (27) (28) (29) (30) and enable a weighting toward intracellular Na + were applied to 35 Cl MR imaging. This way, a fluid suppression could be achieved. The isotropic nominal spatial resolution of 35 Cl IR MR imaging was 10 mm 3 (Fig 2b) . To date, only few disorders that feature a changed cytoplasmic Cl 2 concentration have been described. Malignant brain tumors, especially, glioblastoma multiforme, have in the past shown an elevated Cl 2 content (31). Therefore, we examined two patients with glioblastoma multiforme. As their 35 Cl MR imaging results were similar (Fig E2 [online] ) and 23 Na MR imaging could only be performed in the first patient, we present the images of a 67-year-old female patient (Fig 3) . Conventional contrast-enhanced 1 H MR imaging demonstrated enhancing parts; and 1 H T2-weighted fluid-attenuated IR MR imaging, the perifocal edema (Fig 3a) . Within the affected tissue, concentrationweighted 23 Na and 35 Cl MR imaging revealed increased signal intensities (Fig 3b, 3c, left, respectively) . 23 Na time differences to the calculated SNR ratio was negligible.
In pure 154 mmol/L NaCl solution, T1 and T2* were about 40% shorter for 35 Cl than for 23 Na (Fig 1) . The differences in 35 Cl and 23 Na relaxation times increased with higher concentrations of agar. Thus, for high agar concentrations, the 35 Cl signal can have more loss due to T2* decay than the 23 Na signal, and the calculated SNR can be larger compared with the idealized situation described above.
In Vivo Studies (Human Brain) 35 Cl T2* of healthy human brain turned out to be very short (T2* f = 1.2 milliseconds 6 0.3; T2* s = 7 milliseconds 6 2; A f = 41% 6 10; number of healthy volunteers, three). A monoexponential fit of T1 revealed a value of 9.2 milliseconds 6 0.7 (n = 3). T1 and T2* were evaluated in regions of interest similar to the region of interest (circle 2) in Figure 2a . Data of the individual volunteers are presented in Tables E1 and  E2 (online) . In an acquisition time of 10 minutes, an isotropic nominal spatial resolution of 6 mm 3 was achieved (Fig 2a) . The Cl 2 concentration of CSF was about 100 mmol/L. In brain tissue, the estimated Cl 2 concentration was
Statistical Analysis
This study was designed to demonstrate feasibility of 35 Cl MR imaging. A small number of healthy volunteers (n = 14) and patients (n = 4) were examined. The small population did not permit a statistical analysis to compare both groups.
The relaxation times were calculated by using a mono-and a biexponential model for the T1 (Eq [2] ) and T2* (Eq [3] ), respectively. The signal intensity, SI, was measured as a function of the TI and the TE. Curve fitting was applied with the nonlinear least squares routine (Origin, version 8; OriginLab, Northamptom, Mass).
. (2) . (3) M 0 denotes the equilibrium magnetization. Image noise (N) was taken into account. The relative fractions of the fast component A f and the slow component (A s = 1 2 A f ) of the T2* were set to A f = 0.6 and A s = 0.4, respectively, for phantom imaging, in accordance with the relaxation theory of spin 3/2 nuclei (26). For in vivo imaging A f was used as a free parameter. For the individual values, the standard error of the fits is presented. In addition, mean values and standard deviations of all measurements were calculated.
Results

Phantom Studies
The SNR measurement revealed SNRs of 12 ( 35 Cl MR imaging) and 179 ( 23 Na MR imaging), which leads to an approximately 15-fold lower SNR for 35 Cl MR imaging, compared with 23 Na MR imaging. Thus, the required voxel volumes in 35 Cl MR imaging had to be larger by a factor of approximately 15 than those of 23 Na MR imaging to achieve similar SNR. Acquisition parameters and the phantom solution were selected in a way that the influence of relaxation 35 Cl exhibits much shorter relaxation times than 23 Na.
(32). However, this method is nonlocalized, exposes the patient to neutron radiation, and was applied only very rarely. In contrast, 35 Cl MR imaging provides a noninvasive and harmless means of investigating Cl 2 homeostasis in vivo. We quantified Cl 2 concentrations of calf muscle tissue by employing multiecho sequences and biexponential fitting of T2*.
Previously, in vivo 35 Cl MR imaging data have only been available at smallanimal imaging at 9.4 T (33,34) and 21.1 T (35). Our relaxation time measurements of human brain revealed values that are between the values obtained by Kirsch et al (33) and Schepkin et al (35) in rat brain. We used localized measurements for our study to minimize partial volume effects. However, concentration was estimated with voxel dimensions of 6 mm 3 for brain and 11 mm 3 for skeletal muscle tissue by using 7-T MR imaging. Measurement times for brain and muscle imaging were approximately 10 and 35 minutes, respectively. These would be acceptable for patient examinations in a clinical setting.
The results of our study represent a foray into the noninvasive MR imaging measurement of electrophysiological parameters, such as the resting membrane potential of skeletal muscle cells and the visualization of pathophysiological processes featuring altered Cl 2 channels. Up to now, the total Cl 2 concentration in humans in vivo has only been determined with neutron activation analysis IR MR imaging and 35 Cl IR MR imaging showed dissimilar signal intensity behavior. Whereas large parts of the affected brain area exhibited a decreased 23 Na IR signal intensity (Fig  3b, middle) , the 35 Cl IR signal showed approximately a factor of two higher signal intensity than normal brain tissue (Fig 3c, middle) . 35 Cl subtraction MR imaging (Fig 3c, right) showed qualitatively similar results to 35 Cl IR MR imaging but enabled higher spatial resolution.
In Vivo Studies (Calf Muscle) The 35 Cl T2* of healthy muscle tissue turned out to be shorter (T2* f = 0.37 millisecond 6 0.03, T2* s = 3.0 milliseconds 6 0.7, A f = 69% 6 6, n = 3) than in brain tissue. Data of the individual healthy volunteers and the patients are presented in Table E3 (online) and  Table 2 . The measured Cl 2 concentration of normal muscle tissue was 12 mmol/L 6 2 (n = 3). Data of the individual healthy volunteers and the patients are presented in Table 2 . 23 Na MR imaging revealed a Na + concentration of 17 mmol/L.
To further examine the clinical potential of 35 Cl MR imaging, we examined two patients who had permanent weakness due to a sustained membrane depolarization at presentation. Because this potential reflects Cl 2 concentration gradients, an increased cytoplasmic Cl 2 concentration is expected. Compared with 12 mmol/L 6 2 of normal muscle (Fig 4a) , the Cl 2 concentration was increased to 18 mmol/L 6 3 in the muscle affected with periodic paralysis (Fig  4b) . The muscle Na + concentration was markedly increased (Fig 4d) compared with healthy muscle (Fig 4c) . The second patient also had increased Cl 2 and Na + concentrations at presentation (Fig E3  [online] ).
Discussion
In this study, the feasibility of 35 Cl MR imaging measurements in humans was demonstrated. In addition, we were able to noninvasively visualize pathologic changes of the Cl 2 distribution in diseased tissue. The total Cl partial volume effects-due to the low spatial resolution-might still have led to a slight contamination of CSF signal in the analyzed region of interest.
In this feasibility study, we observed some limitations that need to be considered for quantitative 35 Cl MR imaging. As we demonstrated in the context of muscle imaging, the short 35 Cl T2* results in apparent T2* weighting even for common very short-TE imaging techniques (36) . Thus, accurate concentration quantification requires a characterization of the relaxation times. In this work, however, no relaxation times of tumor tissue were determined. Therefore, the estimated Cl 2 concentrations of tumor tissue might include a systematic error. Relaxation times of healthy brain tissue were applied to calculate the Cl 2 concentration. The short T2* also results in an SNR loss. In the context of calf muscle imaging, approximately 50% of the signal has already been decayed at a TE of 0.35 millisecond. In addition, the very short T2* of 35 Cl leads to blurring and to a decrease in effective spatial resolution. With the applied parameters, an up to 17% broader full width at half maximum of the PSF was calculated. This calculation results in a corresponding loss in spatial resolution. For clinical application, a breakdown into intra-and extracellular Cl 2 concentrations is desirable. However, a direct means of determining distinct values for the intra-and extracellular Cl 2 concentrations is not yet available.
For future clinical studies, the physiologically important intracellular Cl 2 concentration can be calculated from the total Cl 2 concentration, as determined by using 35 Cl MR imaging. This calculation could be performed if a twocompartment model and a known extracellular Cl 2 concentration-which could easily be determined by analyzing the Cl 2 concentration in blood plasma-is assumed. The required values for the intracellular volume fraction are available in the literature (37, 38) and can be estimated from 23 Na MR imaging measurements (39) , as well. The use of literature values for the cell density (37) and the extracellular Cl 2 concentration, 23 Na MR imaging revealed elevated signal intensity in all parts of the tumor, whereas 23 Na IR MR imaging and 23 Na subtraction MR imaging showed parts with reduced and increased signal intensities. (c) Slightly increased signal intensities are also visible in 35 Cl MR imaging. In contrast to 23 Na IR and 23 Na subtraction MR imaging, 35 Cl IR MR imaging and 35 Cl subtraction MR imaging revealed a strong signal increase in the affected brain region. In tumor tissue (white region of interest), a Na + concentration of 104 mmol/L 6 10 and a Cl 2 concentration of 1.12 · (43 mmol/L 6 6) = 48 mmol/L 6 7 were measured. Note, the correction factor (of 1.12) was calculated on the basis of healthy brain tissue. The correction factor of tumor tissue might deviate from this value. Signal from reference tubes B and D is well suppressed in 35 Cl IR MR imaging.
1 H images were acquired at 3 T; 23 Na and 35 Cl images, at 7 T. Each 23 Na and 35 Cl examination required approximately 10 minutes for measurement time. The FOV was 225 3 225 mm 2 . Color bar = measured Cl 2 /Na + concentration in millimoles per liter or measured signal intensity normalized to reference tube A. acquisition, such as sweep imaging with Fourier transformation, might be used (42, 43) . Also the application of chlorine 37 ( 37 Cl) may be used to minimize potential T2* weighting. 37 Cl exhibits a smaller electrical quadrupole moment than 35 Cl (8), which leads to 1.5-to 1.6-fold longer T2* f (26) . As a consequence, 37 Cl MR imaging might provide a more accurate quantification of the in vivo Cl 2 concentration. However, lower SNR is expected due to the reduced natural abundance (24.22%) (8) and the slightly smaller MR sensitivity of the 37 Cl nucleus. Multichannel coils and smaller coils specifically designed for certain areas could further improve image quality and SNR. Once all of the above-mentioned challenges are met, it is likely that a certain level of accuracy will be reached, which will permit solving of the Nernst equation on the basis of MR imaging data. Cell populations' membrane potential could then be estimated with clinically acceptable precision.
In conclusion, our study demonstrates that 35 Cl MR imaging examination of humans can be accomplished with a 7-T whole-body MR imaging system within clinically acceptable acquisition times (10-35 minutes) and voxel dimensions of 6 mm 3 to 11 mm 3 , depending on tissue type. In addition, preliminary patient data confirm that pathophysiological changes of the Cl 2 homeostasis can be visualized.
